Hedge fund manager Kyle Bass, whose America Invents Act reviews of drug patents are under scrutiny by Congress, filed a new petition Thursday taking aim at a patent on Horizon Pharma PLC's arthritis medication Vimovo, which he called a "ridiculous" attempt to patent a combination of common drugs.